Fortress Biotech Announces Closing of Series A Preferred Stock Offering and Full Exercise of Over-Allotment Option

David Linetsky
Point-of-Care Marketing

Suma Ramadas, PhD
Medical Affairs

Joey Cohen
Medication Adherence

Matthew Durham
Omnidynamic Marketing

Liz Kane
Impactful Strategy

Pat Purcell
Meeting Engagement

Daniel Sontupe
Market Access

Bud Bilanich
Success Coach

Matt Turner
Patient Affordability

Paul Theisen
Patient Acquisition

Brenda Snow
Authentic Patient Voice

Amy Giles
Increasing Engagement

Stacey Gandler
Brand Nourishment

Frank Burrell
Scientific Storytelling